Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

Articles published in
Am J Gastroenterol
    August 2022
  1. WONG F
    The Cardiorenal Connection: Is Cardiac Output the Sole Determinant of Renal Dysfunction in Cirrhosis?
    Am J Gastroenterol. 2022;117:1242-1243.
    >> Share

  2. DANIELSEN KV, Wiese S, Busk T, Nabilou P, et al
    Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance Study.
    Am J Gastroenterol. 2022;117:1269-1278.
    >> Share

  3. LONG A, Magrath M, Mihalopoulos M, Rule JA, et al
    Changes in Epidemiology of Acetaminophen Overdoses in an Urban County Hospital After 20 Years.
    Am J Gastroenterol. 2022;117:1324-1328.
    >> Share

    July 2022
  4. PARK D, Houston K, Duong NK, Dharia N, et al
    REDUCTION IN NOSOCOMIAL INFECTIONS IN PATIENTS with CIRRHOSIS DURING THE COVID-19 ERA COMPARED TO PRE-COVID-19: IMPACT OF MASKING AND RESTRICTING VISITATION?
    Am J Gastroenterol. 2022 Jul 21. pii: 00000434-990000000-00442.
    >> Share

  5. VUTIEN P, Berry K, Feng Z, VoPham T, et al
    Combining FIB-4 and liver stiffness into the FIB-5, a single model that accurately predicts complications of portal hypertension.
    Am J Gastroenterol. 2022 Jul 15. pii: 00000434-990000000-00435.
    >> Share

  6. ASRANI SK, Hall L, Reddy V, Ogola G, et al
    Comorbid chronic diseases and survival in compensated and decompensated cirrhosis: a population-based study.
    Am J Gastroenterol. 2022 Jul 15. pii: 00000434-990000000-00436.
    >> Share

    June 2022
  7. BAJAJ JS, Wong F, Kamath PS, Lai JC, et al
    Acute-on-Chronic Liver Failure.
    Am J Gastroenterol. 2022;117:831-834.
    >> Share

  8. SCORLETTI E, Creasy KT, Vujkovic M, Vell M, et al
    Dietary Vitamin E Intake Is Associated With a Reduced Risk of Developing Digestive Diseases and Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2022;117:927-930.
    >> Share

  9. KANN AE, Jepsen P, Madsen LG, Crooks C, et al
    Motivation to Reduce Drinking and Engagement in Alcohol Misuse Treatment in Alcohol-Related Liver Disease: A National Health Survey.
    Am J Gastroenterol. 2022;117:918-922.
    >> Share

    May 2022
  10. ACHANTA CR, Kinhal SV, Imandi V, Singh A, et al
    Motorized Spiral Enteroscope Guided Biliary Intervention for Treatment of Biliary Obstruction in Patient with HepaticoJejunostomy.
    Am J Gastroenterol. 2022 May 9. pii: 00000434-990000000-00372.
    >> Share

  11. CROCOMBE D, Freemantle N, O'Brien A
    Additional Analyses for the Published Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure.
    Am J Gastroenterol. 2022;117:814-815.
    >> Share

  12. MIR BA, Majeed T, Chauhan A
    A New Window to Favorable Outcome in Acute-on-Chronic Liver Failure.
    Am J Gastroenterol. 2022;117:815.
    >> Share

    April 2022
  13. RASHMI KG, Sahoo J
    Correspondence from Rashmi et al " Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial ".
    Am J Gastroenterol. 2022 Apr 15. pii: 00000434-990000000-00344.
    >> Share

  14. TAPPER EB, Salim N, Baki J, Zhao Z, et al
    Pickle Juice Intervention for Cirrhotic Cramps Reduction: The PICCLES Randomized Controlled Trial.
    Am J Gastroenterol. 2022 Apr 13. pii: 00000434-990000000-00331.
    >> Share

  15. YAMASHITA M, Kugiyama T, Takei D, Hara Y, et al
    An Unexpected Case of Fishbone-Induced Liver Abscess Through the Gallbladder.
    Am J Gastroenterol. 2022 Apr 13. pii: 00000434-990000000-00328.
    >> Share

  16. RAO A, Rule JA, Hameed B, Ganger D, et al
    Secular Trends in Severe Idiosyncratic Drug-Induced Liver Injury in North America: An Update From the Acute Liver Failure Study Group Registry.
    Am J Gastroenterol. 2022;117:617-626.
    >> Share

  17. KULKARNI AV, Tirumalle S, Premkumar M, Kumar K, et al
    Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial.
    Am J Gastroenterol. 2022;117:607-616.
    >> Share

    March 2022
  18. SHAHA S, Gao Y, Huang J, Imbertson E, et al
    Successful Treatment of Superior Mesenteric Artery Syndrome with Percutaneous Endoscopic Gastrojejunostomy in a Sarcopenic Patient with Cirrhosis.
    Am J Gastroenterol. 2022 Mar 28. pii: 00000434-990000000-00308.
    >> Share

  19. LAMMERT C, Toal E, Mathur K, Khungar V, et al
    Large Hepatic Adenomas and Hepatic Adenomatosis: A multicenter study of risk factors, interventions, and complications.
    Am J Gastroenterol. 2022 Mar 23. pii: 00000434-990000000-00302.
    >> Share

  20. COSTA MS, Agostinho C, Figueiredo P
    Abdominal Wall Invasion of Hepatocellular Carcinoma.
    Am J Gastroenterol. 2022 Mar 16. pii: 00000434-990000000-00288.
    >> Share

  21. VIEIRA BARBOSA J, Milligan S, Frick A, Broestl J, et al
    Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2022;117:453-461.
    >> Share

  22. DUARTE-ROJO A, Sejdic E
    Artificial Intelligence and the Risk for Intuition Decline in Clinical Medicine.
    Am J Gastroenterol. 2022;117:401-402.
    >> Share

  23. LEE HL, Lin MC, Yeh FC, Tsai MK, et al
    Klebsiella pneumoniae Invasive Syndrome With Ventriculitis.
    Am J Gastroenterol. 2022;117:372.
    >> Share

    February 2022
  24. UFERE NN, Patzer RE, Kavalieratos D, Louissaint J, et al
    Rural-Urban Disparities in Mortality from Cirrhosis in the United States from 1999 to 2019.
    Am J Gastroenterol. 2022 Feb 25. pii: 00000434-990000000-00270.
    >> Share

  25. LEVY MJ, Bendel EC, Bjarnason H, Reisenauer CJ, et al
    Endoscopic Ultrasound Guided Dual Ultrasound Hepatic Cyst Aspiration and Sclerotherapy to Ameliorate Portal Hypertension.
    Am J Gastroenterol. 2022 Feb 17. pii: 00000434-990000000-00261.
    >> Share

  26. LEONTIADIS GI, Longstreth GF
    Evolutionary medicine perspectives: H. pylori, lactose intolerance, and three hypotheses for functional and inflammatory gastrointestinal and hepatobiliary disorders.
    Am J Gastroenterol. 2022 Feb 15. pii: 00000434-990000000-00250.
    >> Share

  27. ZHAO Y, Li X, Yang S, Tao Y, et al
    Small-Diameter Drug-Eluting Beads-Based Transarterial Chemoemboli-zation (DEB-TACE) for Treating Patients With Esophageal Cancer With Acute Bleeding.
    Am J Gastroenterol. 2022 Feb 8. pii: 00000434-990000000-00244.
    >> Share

  28. PENG T, Lu H, Deng L, Li Q, et al
    Diffuse intrahepatic bile duct hamartomas.
    Am J Gastroenterol. 2022 Feb 3. pii: 00000434-990000000-00241.
    >> Share

  29. BAJAJ JS, O'Leary JG, Lai JC, Wong F, et al
    Acute-on-Chronic Liver Failure Clinical Guidelines.
    Am J Gastroenterol. 2022;117:225-252.
    >> Share

  30. VAN KLEEF LA, Hofman A, Voortman T, de Knegt RJ, et al
    Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam Study.
    Am J Gastroenterol. 2022;117:311-318.
    >> Share

  31. YU S, Pan L, Ma J, Cao H, et al
    The Underlying Cause of Esophageal Variceal Bleeding: Hereditary Thrombophilia.
    Am J Gastroenterol. 2022;117:217.
    >> Share

    January 2022
  32. YUAN L, Hanlon CL, Terrault N, Alqahtani S, et al
    Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States.
    Am J Gastroenterol. 2022 Jan 27. pii: 00000434-990000000-00229.
    >> Share

  33. LOUISSAINT J, Grzyb K, Bashaw L, Mohammad RA, et al
    An Electronic Decision Support Intervention Reduces Readmissions for Patients With Cirrhosis.
    Am J Gastroenterol. 2022 Jan 12. pii: 00000434-990000000-00194.
    >> Share

  34. GONZALEZ SA, Velez JCQ
    Board Review Vignette: Lessons Learned in the Management of Hepatorenal Syndrome Type 1 with Terlipressin.
    Am J Gastroenterol. 2022 Jan 5. pii: 00000434-990000000-00198.
    >> Share

    December 2021
  35. AHN JC, Attia ZI, Rattan P, Mullan AF, et al
    Development of the AI-Cirrhosis-ECG (ACE) Score: An electrocardiogram-based deep learning model in cirrhosis.
    Am J Gastroenterol. 2021 Dec 29. pii: 00000434-990000000-00204.
    >> Share

  36. KIM NJ, Rozenberg-Ben-Dror K, Jacob DA, Berry K, et al
    The COVID-19 pandemic highlights opportunities to improve hepatocellular carcinoma screening and diagnosis in a national health system: COVID-19 and HCC screening and diagnosis.
    Am J Gastroenterol. 2021 Dec 29. pii: 00000434-990000000-00201.
    >> Share

  37. HUANG AC, Grab J, Flemming JA, Dodge JL, et al
    Pregnancies With Cirrhosis Are Rising and Associated With Adverse Maternal and Perinatal Outcomes.
    Am J Gastroenterol. 2021 Dec 20. pii: 00000434-990000000-00172.
    >> Share

  38. VAN DE BRUAENE C, Houthoofd B, De Coninck S
    A Hepatic Change of Mind.
    Am J Gastroenterol. 2021 Dec 20. pii: 00000434-990000000-00169.
    >> Share

  39. CACOUB P, Asselah T
    Hepatitis B Virus Infection and Extra-Hepatic Manifestations: A Systemic Disease.
    Am J Gastroenterol. 2021 Dec 16. pii: 00000434-990000000-00166.
    >> Share

  40. LV Y, Bai W, Li K, Wang Z, et al
    Correction to: Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
    Am J Gastroenterol. 2021 Dec 9. pii: 00000434-990000000-00159.
    >> Share

  41. LIZAOLA-MAYO BC, Mathur AK, Borad MJ, Jadlowiec CC, et al
    Immunotherapy as a Downstaging Tool for Liver Transplantation in Hepatocellular Carcinoma.
    Am J Gastroenterol. 2021;116:2478-2480.
    >> Share

  42. HARRISON SA, Baum SJ, Gunn NT, Younes ZH, et al
    Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2021;116:2399-2409.
    >> Share

  43. BERK C, Ammar T, Lee BT
    Acute Liver Failure due to Manufactured Alkaline Water: A Case Series of "Real Water"-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:2476-2477.
    >> Share

  44. MEDAS R, Garrido I, Coelho R, Macedo G, et al
    Extensive Abdominal Wall Hematoma After Paracentesis.
    Am J Gastroenterol. 2021;116:2325.
    >> Share

    November 2021
  45. KEHAR M, Griffiths R, Flemming JA
    Increasing Incidence of Cirrhosis Over the Past 2 Decades Among Children in Ontario, Canada.
    Am J Gastroenterol. 2021 Nov 18. pii: 00000434-990000000-00150.
    >> Share

  46. DAWOD E, Nieto J, Saab S
    Endoscopic Ultrasound-Guided Liver Biopsy: Where Do We Stand?
    Am J Gastroenterol. 2021 Nov 17. pii: 00000434-990000000-00146.
    >> Share

  47. DUONG NK, Shrestha S, Park D, Shahab O, et al
    Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis.
    Am J Gastroenterol. 2021 Nov 5. pii: 00000434-990000000-00135.
    >> Share

  48. YANG D, Zhuang B, Xie X
    Hepatic Angiofibroma of Soft tissue: A Case Report.
    Am J Gastroenterol. 2021 Nov 4. pii: 00000434-990000000-00140.
    >> Share

  49. KIM Y, Chang Y, Kwon MJ, Hong YS, et al
    Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults.
    Am J Gastroenterol. 2021;116:2270-2278.
    >> Share

    October 2021
  50. WEBER S, Gerbes AL
    Ashwagandha-Induced Liver Injury: Self-Reports on Commercial Websites as Useful Adjunct Tools for Causality Assessment.
    Am J Gastroenterol. 2021;116:2151-2152.
    >> Share

  51. GAO X, Gao Y, Ye X, Kang W, et al
    Rare Multiple Liver Lesions With Concentric Circle Pattern.
    Am J Gastroenterol. 2021;116:1979.
    >> Share

  52. LIN FP, Visina JM, Bloomer PM, Dunn MA, et al
    Prehabilitation-Driven Changes in Frailty Metrics Predict Mortality in Patients With Advanced Liver Disease.
    Am J Gastroenterol. 2021;116:2105-2117.
    >> Share

  53. BOIKE JR, Mazumder NR, Kolli KP, Ge J, et al
    Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era-An ALTA Group Study.
    Am J Gastroenterol. 2021;116:2079-2088.
    >> Share

  54. JOHNSON DA
    "Sickeningly Sweet".... High-Fructose Corn Syrup-Caveat Emptor!
    Am J Gastroenterol. 2021;116:1970-1971.
    >> Share

    September 2021
  55. TRIPATHI PR, Sen Sarma M, Yachha SK, Aggarwal A, et al
    Relative Adrenal Insufficiency in Decompensated Cirrhotic Children: Does It Affect Outcome?
    Am J Gastroenterol. 2021 Sep 10. pii: 00000434-990000000-00094.
    >> Share

  56. LEE HW, Park SY, Lee YR, Lee H, et al
    Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL.
    Am J Gastroenterol. 2021 Sep 10. pii: 00000434-990000000-00096.
    >> Share

  57. CHINA L, Freemantle N, Forrest E, Kallis Y, et al
    Targeted Albumin Therapy Does Not Improve Short-Term Outcome in Hyponatremic Patients Hospitalized With Complications of Cirrhosis: Data From the ATTIRE Trial.
    Am J Gastroenterol. 2021 Sep 9. pii: 00000434-990000000-00104.
    >> Share

  58. SHAH BJ, Onken JE, Edgar L, Jou JH, et al
    Development of gastroenterology and transplant hepatology milestones 2.0: a guide for programs, faculty, and fellows.
    Am J Gastroenterol. 2021 Sep 7. pii: 00000434-990000000-00088.
    >> Share

  59. BLOOM PP, Robin J, Xu M, Arvind A, et al
    Hepatic Encephalopathy is Associated With Slow Speech on Objective Assessment.
    Am J Gastroenterol. 2021;116:1950-1953.
    >> Share

  60. CASTELLANA M, Donghia R, Guerra V, Procino F, et al
    Fibrosis-4 Index vs Nonalcoholic Fatty Liver Disease Fibrosis Score in Identifying Advanced Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
    Am J Gastroenterol. 2021;116:1833-1841.
    >> Share

  61. THULUVATH PJ, Alukal JJ, Zhang T
    A Scoring Model to Predict In-Hospital Mortality in Patients With Budd-Chiari Syndrome.
    Am J Gastroenterol. 2021;116:1905-1912.
    >> Share

    August 2021
  62. SACK JS, Liu AF, Gray M, Roat J, et al
    Association of Terry Nails With Liver Cirrhosis.
    Am J Gastroenterol. 2021 Aug 27. pii: 00000434-990000000-00085.
    >> Share

  63. FU XL, Chen HL
    COVID-19 Vaccine for Chronic Gastroenterology and Hepatology Patients: A Need for Better Evidence.
    Am J Gastroenterol. 2021 Aug 17. pii: 00000434-990000000-00073.
    >> Share

  64. RODRIGUEZ M, Gonzalez-Dieguez ML, Varela M, Cadahia V, et al
    Impact of Alcohol Abstinence on the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Cirrhosis.
    Am J Gastroenterol. 2021 Aug 16. pii: 00000434-990000000-00111.
    >> Share

  65. SCHNEIDER CV, Fromme M, Schneider KM, Bruns T, et al
    Mortality in Patients With Genetic and Environmental Risk of Liver Disease.
    Am J Gastroenterol. 2021;116:1741-1745.
    >> Share

  66. TAGUCHI YV, Snyder DL, Shah JB, Dickson RC, et al
    Deglutition Syncope After Variceal Band Ligation.
    Am J Gastroenterol. 2021;116:1763.
    >> Share

  67. HASHEMIAN M, Merat S, Poustchi H, Jafari E, et al
    Red Meat Consumption and Risk of Nonalcoholic Fatty Liver Disease in a Population With Low Meat Consumption: The Golestan Cohort Study.
    Am J Gastroenterol. 2021;116:1667-1675.
    >> Share

    July 2021
  68. MOCTEZUMA-VELAZQUEZ C, Abraldes JG
    Statins and Liver Cancer in Cirrhosis: The Most Relevant Questions Are Still Unanswered.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00051.
    >> Share

  69. LABENZ C, Labenz J
    Proton Pump Inhibitors in Patients With Liver Cirrhosis: Evidence to Improve Their Battered Reputation.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00048.
    >> Share

  70. USHIDA K, Shimizu M, Yamamoto Y, Momosaki R, et al
    Strategies to Improve Exercise Adherence in Patients With Cirrhosis.
    Am J Gastroenterol. 2021 Jul 13. pii: 00000434-990000000-00043.
    >> Share

  71. PINYOPORNPANISH K, Al-Yaman W, Butler RS, Carey W, et al
    Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
    Am J Gastroenterol. 2021 Jul 2. pii: 00000434-990000000-00036.
    >> Share

  72. MATTOS AZ, Leao GS, Bombassaro IZ, Chiesa T, et al
    Definitions for Acute-on-Chronic Liver Failure: In Dubio Pro Reo.
    Am J Gastroenterol. 2021;116:1550.
    >> Share

  73. VAN J, Aloman C, Reau N
    Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver Disease.
    Am J Gastroenterol. 2021 Jul 1. pii: 00000434-990000000-00032.
    >> Share

    June 2021
  74. JINDAL A, Mukund A
    Management of Portal Vein Thrombosis in Cirrhosis-Need a Closer Look!
    Am J Gastroenterol. 2021 Jun 30. pii: 00000434-990000000-00025.
    >> Share

  75. ZHAI LL, Tang ZG
    Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: Several Confounding Factors.
    Am J Gastroenterol. 2021 Jun 23. pii: 00000434-990000000-00016.
    >> Share

  76. REIG A, Alvarez-Navascues C, Vergara M, Gomez-Dominguez E, et al
    Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
    Am J Gastroenterol. 2021 Jun 23. pii: 00000434-990000000-00017.
    >> Share

  77. ACHARYA C, Nadhem O, Shaw J, Hassouneh R, et al
    Liver-Unrelated Comorbid Conditions Do Not Affect Cognitive Performance or Hepatic Encephalopathy Progression in Cirrhosis.
    Am J Gastroenterol. 2021 Jun 18. pii: 00000434-990000000-00012.
    >> Share

  78. LOUISSAINT J, May FP, Williams S, Tapper EB, et al
    Effective Mentorship as a Means to Recruit, Retain, and Promote Underrepresented Minorities in Academic Gastroenterology and Hepatology.
    Am J Gastroenterol. 2021;116:1110-1113.
    >> Share

  79. CRAVEN LJ, Parvathy SN, Burton JP, Silverman MS, et al
    Response to Ianiro et al.
    Am J Gastroenterol. 2021;116:1361-1362.
    >> Share

  80. IANIRO G, Porcari S, Gasbarrini A, Cammarota G, et al
    Quantity of Donor Stool for Fecal Microbiota Transplantation: The More, the Better?
    Am J Gastroenterol. 2021;116:1360-1361.
    >> Share

  81. BENMASSAOUD A, Tsochatzis E
    Response to Debnath and Rathi.
    Am J Gastroenterol. 2021;116:1358-1359.
    >> Share

  82. DEBNATH P, Rathi P
    Sarcopenia and TIPS: How Best to Measure Muscle Mass.
    Am J Gastroenterol. 2021;116:1358.
    >> Share

  83. WU F, Pahkala K, Juonala M, Jaakkola J, et al
    Childhood and Adulthood Passive Smoking and Nonalcoholic Fatty Liver in Midlife: A 31-year Cohort Study.
    Am J Gastroenterol. 2021;116:1256-1263.
    >> Share

    May 2021
  84. HERNANDEZ-CONDE M, Llop E, Gomez-Pimpollo L, Fernandez Carrillo C, et al
    Adding Branched-Chain Amino Acids to an Enhanced Standard-of-Care Treatment Improves Muscle Mass of Cirrhotic Patients With Sarcopenia: A Placebo-Controlled Trial.
    Am J Gastroenterol. 2021 May 26. pii: 00000434-900000000-98756.
    >> Share

  85. FARUQUI S, Okoli FC, Olsen SK, Feldman DM, et al
    Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
    Am J Gastroenterol. 2021 May 17. pii: 00000434-900000000-98779.
    >> Share

  86. JOHN BV, Khakoo NS, Schwartz KB, Aitchenson G, et al
    Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.
    Am J Gastroenterol. 2021 May 13. pii: 00000434-900000000-98782.
    >> Share

  87. GOET JC, Murillo Perez CF, Harms MH, Floreani A, et al
    A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2021 May 4. pii: 00000434-900000000-98792.
    >> Share

  88. WANG R, Yang L, Hu C, Yan J, et al
    A Tip of the Iceberg on the Mechanism of SARS-CoV-2-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:1097-1098.
    >> Share

  89. BENMASSAOUD A, Tsochatzis E
    Response to Anand and Sharma.
    Am J Gastroenterol. 2021;116:1094-1095.
    >> Share

  90. BJORNSSON HK, Bjornsson ES
    Database Studies on Drug-Induced Liver Injury: The Importance of Causality Assessment.
    Am J Gastroenterol. 2021;116:1090-1091.
    >> Share

  91. CHALASANI NP, Maddur H, Russo MW, Wong RJ, et al
    ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:878-898.
    >> Share

  92. VILAR-GOMEZ E, Pirola CJ, Sookoian S, Wilson LA, et al
    Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD.
    Am J Gastroenterol. 2021;116:994-1006.
    >> Share

  93. YATACO ML, Bowman AW, Keaveny AP
    Management of the Incidental Liver Lesion.
    Am J Gastroenterol. 2021;116:855-861.
    >> Share

  94. ESLAM M, Wong GL, Hashem AM, Chan HL, et al
    A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients.
    Am J Gastroenterol. 2021;116:984-993.
    >> Share

    April 2021
  95. GROVER I, Gunjan D, Singh N, Benjamin J, et al
    Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98797.
    >> Share

  96. TRAN S, Jeong D, Henry L, Cheung RC, et al
    Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98796.
    >> Share

  97. THORNTON C, Somayaji R, Parkins M, Swain MG, et al
    Characteristics and Outcomes of Children With Cystic Fibrosis Hospitalized With Cirrhosis in the United States.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98795.
    >> Share

  98. MA C, Qian AS, Nguyen NH, Stukalin I, et al
    Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016.
    Am J Gastroenterol. 2021 Apr 28. doi: 10.14309/ajg.0000000000001292.
    >> Share

  99. KAWAGUCHI Y, Hasegawa K, Hagiwara Y, De Bellis M, et al
    Effect of Diameter and Number of Hepatocellular Carcinomas on Survival After Resection, Transarterial Chemoembolization, and Ablation.
    Am J Gastroenterol. 2021 Apr 21. pii: 00000434-900000000-98811.
    >> Share

  100. SERPER M, Reddy KR, Bewtra M, Ahmad N, et al
    COVID-19 Vaccine Perceptions Among Patients With Chronic Disease in a Large Gastroenterology and Hepatology Practice.
    Am J Gastroenterol. 2021 Apr 19. pii: 00000434-900000000-98813.
    >> Share

  101. SHARMA S, Saraya A
    Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?
    Am J Gastroenterol. 2021 Apr 9. pii: 00000434-900000000-98829.
    >> Share

  102. KHALILI M, Kleiner DE, King WC, Sterling RK, et al
    Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98823.
    >> Share

  103. SONI D, Roy A, De A, Verma N, et al
    MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?
    Am J Gastroenterol. 2021;116:836-837.
    >> Share

  104. MORTON A
    Measuring Serum Sodium in Cirrhosis: Regarding "Hyponatremia in Cirrhosis: An Update".
    Am J Gastroenterol. 2021;116:835.
    >> Share

  105. PONS M, Augustin S, Scheiner B, Guillaume M, et al
    Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Am J Gastroenterol. 2021;116:723-732.
    >> Share

  106. LAI JC, Dodge JL, Kappus MR, Wong R, et al
    A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE).
    Am J Gastroenterol. 2021;116:717-722.
    >> Share

  107. KOTANI K, Uchida-Kobayashi S, Yoshida K, Kawamura E, et al
    Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma.
    Am J Gastroenterol. 2021;116:631.
    >> Share

  108. TAPPER EB
    Finding Common Ground With Our MASQs Off.
    Am J Gastroenterol. 2021;116:837.
    >> Share

  109. ALUKAL JJ, Thuluvath PJ
    Reply to Morton.
    Am J Gastroenterol. 2021;116:835-836.
    >> Share

  110. YAMADA G, Hagiwara Y, Kimura T, Takeuchi Y, et al
    Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals.
    Am J Gastroenterol. 2021;116:733-740.
    >> Share

  111. KOK B, McNeely M, Watt M, Tandon P, et al
    Exercise Only Works If You Do It! The Holy Grail of Adherence.
    Am J Gastroenterol. 2021;116:673-674.
    >> Share

    March 2021
  112. ROGAL S, Youk A, Agbalajobi O, Zhang H, et al
    Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
    Am J Gastroenterol. 2021 Mar 30. pii: 00000434-900000000-98834.
    >> Share

  113. AYOUB F, Ouni A, Case R, Ladna M, et al
    Dissemination of Gastroenterology and Hepatology Research on Social Media Platforms Is Associated With Increased Citation Count.
    Am J Gastroenterol. 2021 Mar 22. pii: 00000434-900000000-98848.
    >> Share

  114. JANSSON-KNODELL CL, Calderon G, Weber R, Ghabril M, et al
    Small Intestine Varices in Cirrhosis at a High-Volume Liver Transplant Center: A Retrospective Database Study and Literature Review.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98858.
    >> Share

  115. CHANDEL S, Singh V
    Hyponatremia in Cirrhosis: Role of Vasopressors.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98857.
    >> Share

  116. NAM H, Lee SW, Kwon JH, Lee HL, et al
    Prediction of Hepatocellular Carcinoma by On-Therapy Response of Noninvasive Fibrosis Markers in Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98856.
    >> Share

  117. GIL-GOMEZ A, Ampuero J, Rojas A, Gallego-Duran R, et al
    Development and Validation of a Clinical-Genetic Risk Score to Predict Hepatic Encephalopathy in Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2021 Mar 2. pii: 00000434-900000000-98817.
    >> Share

  118. WONG RJ, Jain MK, Therapondos G, Niu B, et al
    Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems.
    Am J Gastroenterol. 2021 Mar 1. pii: 00000434-900000000-98873.
    >> Share

  119. BRAILLON A
    Hepatocellular Carcinoma in Women: Could Tobacco Matter More than Sex?
    Am J Gastroenterol. 2021;116:617.
    >> Share

  120. SUBRAMANIAM M, Azad N, Wasan SK, Long MT, et al
    Equal Opportunity: Women Representation on Editorial Boards and Authorship of Editorials in Gastroenterology and Hepatology Journals.
    Am J Gastroenterol. 2021;116:613-616.
    >> Share

  121. MONROSE E, Bui A, Rosenbluth E, Dickstein D, et al
    Burden of Future Liver Abnormalities in Patients With Intrahepatic Cholestasis of Pregnancy.
    Am J Gastroenterol. 2021;116:568-575.
    >> Share

  122. SHAUKAT A, Oxentenko AS
    The Time Is Now to Understand and Address Sex-Related Disparities in Gastroenterology and Hepatology.
    Am J Gastroenterol. 2021;116:441-443.
    >> Share

  123. PHIPPS M, Wattacheril J
    Response to Braillon.
    Am J Gastroenterol. 2021;116:617-618.
    >> Share

  124. VALENTIN N, Guerrido I, Rozenshteyn F, Pinotti R, et al
    Pregnancy Outcomes After Liver Transplantation: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2021;116:491-504.
    >> Share

    February 2021
  125. BAJAJ JS
    The Three Villages of Hepatic Encephalopathy.
    Am J Gastroenterol. 2021 Feb 26. pii: 00000434-900000000-98870.
    >> Share

  126. LV Y, Bai W, Li K, Wang Z, et al
    Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
    Am J Gastroenterol. 2021 Feb 25. pii: 00000434-900000000-98874.
    >> Share

  127. TOSETTI G, Degasperi E, Farina E, D'Ambrosio R, et al
    Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Beta-Blocker Therapy.
    Am J Gastroenterol. 2021 Feb 18. pii: 00000434-900000000-98881.
    >> Share

  128. TAN HK, Teng MLP, Soh AYS, Cheo SHY, et al
    Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites.
    Am J Gastroenterol. 2021 Feb 1. doi: 10.14309/ajg.0000000000001176.
    >> Share

    January 2021
  129. SAWAS T, Dilmaghani S, Dhaliwal L, Wang KK, et al
    Risk Factor Profiles Can Distinguish Esophageal Adenocarcinoma From Barrett's Esophagus.
    Am J Gastroenterol. 2021;116:198-201.
    >> Share

  130. LEE JI, Lee HW, Lee KS, Lee HS, et al
    Effects of Statin Use on the Development and Progression of Nonalcoholic Fatty Liver Disease: A Nationwide Nested Case-Control Study.
    Am J Gastroenterol. 2021;116:116-124.
    >> Share

    December 2020
  131. LAI JC, Dodge JL, Kappus MR, Wong R, et al
    A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE).
    Am J Gastroenterol. 2020;Publish Ahead of Print.
    >> Share

  132. YOUNOSSI ZM, Noureddin M, Bernstein D, Kwo P, et al
    Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations.
    Am J Gastroenterol. 2020 Dec 7. doi: 10.14309/ajg.0000000000001054.
    >> Share

    November 2020
  133. KIM NJ, Jacob DA, Ioannou GN, John BV, et al
    Rates and Predictors of Undergoing Different Hepatocellular Carcinoma Screening Tests in Patients With Cirrhosis.
    Am J Gastroenterol. 2020 Nov 26. doi: 10.14309/ajg.0000000000001000.
    >> Share

  134. SHARMA S, Agarwal S, Anand A
    Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Liver Disease: Whom and How to Screen?
    Am J Gastroenterol. 2020 Nov 23. doi: 10.14309/ajg.0000000000001078.
    >> Share

  135. ANAND A, Sharma S
    Sarcopenia Does Not Worsen Outcomes in Patients With Refractory Ascites Under Transjugular Intrahepatic Portosystemic Shunt Placement-Preliminary Evidence?
    Am J Gastroenterol. 2020 Nov 10. doi: 10.14309/ajg.0000000000001053.
    >> Share

  136. BENMASSAOUD A, Roccarina D, Arico F, Leandro G, et al
    Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites.
    Am J Gastroenterol. 2020;115:1911-1914.
    >> Share

  137. CHEDID VG, Kamath AA, M Knudsen J, Frimannsdottir K, et al
    Three-Dimensional-Printed Liver Model Helps Learners Identify Hepatic Subsegments: A Randomized-Controlled Cross-Over Trial.
    Am J Gastroenterol. 2020;115:1906-1910.
    >> Share

  138. ARE VS, Knapp SM, Banerjee A, Shamseddeen H, et al
    Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment.
    Am J Gastroenterol. 2020;115:1849-1856.
    >> Share

  139. ALUKAL JJ, John S, Thuluvath PJ
    Hyponatremia in Cirrhosis: An Update.
    Am J Gastroenterol. 2020;115:1775-1785.
    >> Share

  140. AHMED O, Pillai A
    Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy.
    Am J Gastroenterol. 2020;115:1733-1736.
    >> Share

    October 2020
  141. LIU W, Wang S, Guo J, Liu X, et al
    A Bolt Method of Treating the Stent Migration After Endoscopic Ultrasound-Guided Hepaticogastrostomy.
    Am J Gastroenterol. 2020 Oct 28. doi: 10.14309/ajg.0000000000000938.
    >> Share

  142. LEE BP, Dodge JL, Terrault NA
    Excess Mortality After Liver Transplantation in Young Women With Alcohol-Associated Liver Disease.
    Am J Gastroenterol. 2020 Oct 28. doi: 10.14309/ajg.0000000000001007.
    >> Share

  143. THULUVATH PJ, To C, Amjad W
    Role of Locoregional Therapies in Patients With Hepatocellular Cancer Awaiting Liver Transplantation.
    Am J Gastroenterol. 2020 Oct 23. doi: 10.14309/ajg.0000000000000999.
    >> Share

  144. MORTON A
    Measuring Serum Sodium in Cirrhosis: Regarding "Hyponatremia in Cirrhosis: An Update".
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001011.
    >> Share

  145. SONI D, Roy A, De A, Verma N, et al
    MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001010.
    >> Share

  146. ARE VS, Knapp SM, Banerjee A, Shamseddeen H, et al
    Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment.
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000000911.
    >> Share

  147. KIM JH, Kim DJ, Kwon CI
    Pseudoaneurysmal Rupture of the Hepatic Artery Caused by a Biliary Plastic Stent.
    Am J Gastroenterol. 2020 Oct 15. doi: 10.14309/ajg.0000000000000982.
    >> Share

  148. REIG A, Norman GL, Pares A
    Surrogate Markers for Antimitochondrial Antibody Negative Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Oct 15. doi: 10.14309/ajg.0000000000000980.
    >> Share

  149. OZDOGAN E, Doganay L, Can D, Arikan C, et al
    Disease Course and Treatment Response of Eosinophilic Gastrointestinal Diseases in Children With Liver Transplantation: Long-Term Follow-Up.
    Am J Gastroenterol. 2020 Oct 13. doi: 10.14309/ajg.0000000000000934.
    >> Share

  150. BENMASSAOUD A, Roccarina D, Arico F, Leandro G, et al
    Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites.
    Am J Gastroenterol. 2020 Oct 12. doi: 10.14309/ajg.0000000000000959.
    >> Share

  151. HU C, Anjur V, Saboo K, Reddy KR, et al
    Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000971.
    >> Share

  152. PILLAI A, Ahn J, Kulik L
    Integrating Genomics Into Clinical Practice in Hepatocellular Carcinoma: The Challenges Ahead.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000843.
    >> Share

  153. PONS M, Augustin S, Scheiner B, Guillaume M, et al
    Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000994.
    >> Share

  154. KALAMBOKIS GN, Tsiakas I, Filippas-Ntekuan S, Christaki M, et al
    Empagliflozin Eliminates Refractory Ascites and Hepatic Hydrothorax in a Patient With Primary Biliary Cirrhosis.
    Am J Gastroenterol. 2020 Oct 7. doi: 10.14309/ajg.0000000000000995.
    >> Share

  155. CHEN PT, Tzeng HL, Wang HP, Liu KL, et al
    Caput Medusae Bleeding.
    Am J Gastroenterol. 2020;115:1570.
    >> Share

    September 2020
  156. AHMED O, Pillai A
    Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy.
    Am J Gastroenterol. 2020 Sep 30. doi: 10.14309/ajg.0000000000000931.
    >> Share

  157. GRANITO A, Muratori L, Tovoli F, Muratori P, et al
    Surrogate Markers for Antimitochondrial Antibody-Negative Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Sep 28. doi: 10.14309/ajg.0000000000000928.
    >> Share

  158. WONG RJ, Saab S, Konyn P, Sundaram V, et al
    Rural-Urban Geographical Disparities in Hepatocellular Carcinoma Incidence Among US Adults, 2004-2017.
    Am J Gastroenterol. 2020 Sep 24. doi: 10.14309/ajg.0000000000000948.
    >> Share

  159. CHEDID VG, Kamath AA, M Knudsen J, Frimannsdottir K, et al
    Three-Dimensional-Printed Liver Model Helps Learners Identify Hepatic Subsegments: A Randomized-Controlled Cross-Over Trial.
    Am J Gastroenterol. 2020 Sep 24. doi: 10.14309/ajg.0000000000000958.
    >> Share

  160. CARBALLO-FOLGOSO L, Alvarez-Navascues C, Rodriguez M
    Acute Liver Failure Associated With Ulipristal Acetate: A Case Report.
    Am J Gastroenterol. 2020;115:1542-1544.
    >> Share

  161. KIM D, Vazquez-Montesino LM, Escober JA, Fernandes CT, et al
    Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality.
    Am J Gastroenterol. 2020;115:1496-1504.
    >> Share

  162. ZHAO J, Blais JE, Chui CSL, Suh IH, et al
    Association Between Nonvitamin K Antagonist Oral Anticoagulants or Warfarin and Liver Injury: A Cohort Study.
    Am J Gastroenterol. 2020;115:1513-1524.
    >> Share

    August 2020
  163. WHITFIELD JB, Masson S, Liangpunsakul S, Mueller S, et al
    Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers.
    Am J Gastroenterol. 2020 Aug 31. doi: 10.14309/ajg.0000000000000833.
    >> Share

  164. CAO Z, Liu Y, Cai M, Xu Y, et al
    The Use of NACSELD and EASL-CLIF Classification Systems of ACLF in the Prediction of Prognosis in Hospitalized Patients With Cirrhosis.
    Am J Gastroenterol. 2020 Aug 27. doi: 10.14309/ajg.0000000000000771.
    >> Share

  165. YE L, Zhang C, Seidensticker M, Mayerle J, et al
    Durable Complete Response of Brain Metastasis From Hepatocellular Carcinoma On Treatment With Nivolumab and Radiation Treatment.
    Am J Gastroenterol. 2020 Aug 26. doi: 10.14309/ajg.0000000000000800.
    >> Share

  166. LOPEZ-TOBARUELA JM, Valverde-Lopez F, Lopez de Hierro-Ruiz M, Redondo-Cerezo E, et al
    Hepatic Abscess After Biodegradable Esophageal Stent Placement: A Rare Complication.
    Am J Gastroenterol. 2020 Aug 19. doi: 10.14309/ajg.0000000000000821.
    >> Share

  167. TAPPER EB, Zhao L, Nikirk S, Baki J, et al
    Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis.
    Am J Gastroenterol. 2020 Aug 6. doi: 10.14309/ajg.0000000000000762.
    >> Share

  168. ALUKAL JJ, John S, Thuluvath PJ
    Hyponatremia in Cirrhosis: An Update.
    Am J Gastroenterol. 2020 Aug 6. doi: 10.14309/ajg.0000000000000786.
    >> Share

  169. REVERTER E, Ott P
    Compensated Cirrhosis and 20 mm Hg: A Point of No Return?
    Am J Gastroenterol. 2020 Aug 5. doi: 10.14309/ajg.0000000000000770.
    >> Share

  170. ZHANG X, Tang C, Tian D, Hou X, et al
    Management of Digestive Disorders and Procedures Associated With COVID-19.
    Am J Gastroenterol. 2020;115:1153-1155.
    >> Share

  171. YOUNES R, Govaere O, Petta S, Miele L, et al
    Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2020;115:1289-1292.
    >> Share

    July 2020
  172. SAMOYLOVA ML, Kapila N, McElroy L, Suhocki P, et al
    Gastrohepatic Fistula After Y-90 Embolization of Hepatocellular Carcinoma.
    Am J Gastroenterol. 2020 Jul 31. doi: 10.14309/ajg.0000000000000793.
    >> Share

  173. LEVY C, Bowlus CL
    Role of Antinuclear Antibodies in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Jul 22. doi: 10.14309/ajg.0000000000000765.
    >> Share

  174. GAO F, Zheng KI, Fan YC, Targher G, et al
    ACE2: A Linkage for the Interplay Between COVID-19 and Decompensated Cirrhosis.
    Am J Gastroenterol. 2020 Jul 16. doi: 10.14309/ajg.0000000000000780.
    >> Share

  175. KOTANI K, Uchida-Kobayashi S, Yoshida K, Kawamura E, et al
    Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma.
    Am J Gastroenterol. 2020 Jul 14. doi: 10.14309/ajg.0000000000000747.
    >> Share

  176. RUBIN JN, Gilman CAL, Gasmi B, Stern WR, et al
    Hepatocellular Carcinoma Where You Least Expect It.
    Am J Gastroenterol. 2020;115:1134-1136.
    >> Share

  177. BAJAJ JS, Brenner DM, Cai Q, Cash BD, et al
    Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology.
    Am J Gastroenterol. 2020;115:1007-1018.
    >> Share

  178. BAJAJ JS, Lauridsen M, Tapper EB, Duarte-Rojo A, et al
    Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus.
    Am J Gastroenterol. 2020;115:989-1002.
    >> Share

  179. BOWER RJ, Frenette C
    Reevaluating Goals of Therapy in Primary Biliary Cholangitis: Is Good Enough Is Not Good Enough Anymore?
    Am J Gastroenterol. 2020;115:1024-1025.
    >> Share

  180. CRAVEN L, Rahman A, Nair Parvathy S, Beaton M, et al
    Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial.
    Am J Gastroenterol. 2020;115:1055-1065.
    >> Share

    June 2020
  181. BAJAJ JS, Brenner DM, Cai Q, Cash BD, et al
    Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology.
    Am J Gastroenterol. 2020 Jun 23. doi: 10.14309/ajg.0000000000000709.
    >> Share

  182. PARIKH ND, Singal AG, Hutton DW, Tapper EB, et al
    Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms.
    Am J Gastroenterol. 2020 Jun 9. doi: 10.14309/ajg.0000000000000715.
    >> Share

  183. KOSHY AN, Farouque O, Gow PJ
    Response to Singh, et al.
    Am J Gastroenterol. 2020;115:951-952.
    >> Share

  184. MANCUSO A, Amata M, Politi F, Mitra M, et al
    Controversies in Budd-Chiari Syndrome Management: Potential Role of Liver Stiffness.
    Am J Gastroenterol. 2020;115:952-953.
    >> Share

  185. SAAB S, Kim NG, Lee EW
    Practical Tips on TIPS: When and When Not to Request It.
    Am J Gastroenterol. 2020;115:797-800.
    >> Share

  186. XU L, Xie J, Chen S, Chen Y, et al
    Light-to-Moderate Alcohol Consumption Is Associated With Increased Risk of Type 2 Diabetes in Individuals With Nonalcoholic Fatty Liver Disease: A Nine-Year Cohort Study.
    Am J Gastroenterol. 2020;115:876-884.
    >> Share

    May 2020
  187. REIG A, Norman GL, Garcia M, Shums Z, et al
    Novel Anti-Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 May 27. doi: 10.14309/ajg.0000000000000690.
    >> Share

  188. PHIPPS M, Livanos A, Guo A, Pomenti S, et al
    Gender Matters: Characteristics of Hepatocellular Carcinoma in Women From a Large, Multicenter Study in the United States.
    Am J Gastroenterol. 2020 May 22. doi: 10.14309/ajg.0000000000000643.
    >> Share

  189. JINDAL A, Bhardwaj A, Kumar G, Sarin SK, et al
    Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient >/=20 mm Hg.
    Am J Gastroenterol. 2020 May 21. doi: 10.14309/ajg.0000000000000653.
    >> Share

  190. PATIDAR KR, Shamseddeen H, Xu C, Ghabril MS, et al
    Hospital-Acquired Versus Community-Acquired Acute Kidney Injury in Patients With Cirrhosis: A Prospective Study.
    Am J Gastroenterol. 2020 May 5. doi: 10.14309/ajg.0000000000000670.
    >> Share

  191. VIJAYARAGHAVAN R, Jindal A, Arora V, Choudhary A, et al
    Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.
    Am J Gastroenterol. 2020;115:729-737.
    >> Share

    April 2020
  192. RUBIN JN, Gilman CAL, Gasmi B, Stern WR, et al
    Hepatocellular Carcinoma Where You Least Expect It.
    Am J Gastroenterol. 2020 Apr 10. doi: 10.14309/ajg.0000000000000616.
    >> Share

  193. MOON AM, Kim HP, Barritt AS 4th, Darling J, et al
    A Quality Improvement Initiative Results in Improved Rates of Timely Postvariceal Bleeding Surveillance Endoscopy.
    Am J Gastroenterol. 2020;115:625-628.
    >> Share

  194. HAN E, Lee YH, Kim YD, Kim BK, et al
    Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk.
    Am J Gastroenterol. 2020;115:584-595.
    >> Share

    March 2020
  195. SALIM TI, Nestlerode LC, Lucatorto EL, Wasserman TL, et al
    Frailty as Tested by Gait Speed Is a Risk Factor for Liver Transplant Respiratory Complications.
    Am J Gastroenterol. 2020 Mar 31. doi: 10.14309/ajg.0000000000000609.
    >> Share

  196. BAJAJ JS, Lauridsen M, Tapper EB, Duarte-Rojo A, et al
    Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus.
    Am J Gastroenterol. 2020 Mar 30. doi: 10.14309/ajg.0000000000000603.
    >> Share

  197. KAPILA N, Dorsey YC, Shah J, King L, et al
    Transjugular Intrahepatic Portosystemic Shunt for a Challenging Pregnancy.
    Am J Gastroenterol. 2020 Mar 26. doi: 10.14309/ajg.0000000000000602.
    >> Share

  198. LEE JK, Merchant SA, Schneider JL, Jensen CD, et al
    Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population.
    Am J Gastroenterol. 2020 Mar 20. doi: 10.14309/ajg.0000000000000591.
    >> Share

    February 2020
  199. DAI C, Jiang M
    Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease?
    Am J Gastroenterol. 2020;115:303-304.
    >> Share

  200. MILLER ED, Abu-Sbeih H, Styskel B, Nogueras Gonzalez GM, et al
    Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors.
    Am J Gastroenterol. 2020;115:251-261.
    >> Share

    January 2020
  201. GORDON SC, Wu KH, Lindor K, Bowlus CL, et al
    Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Jan 27. doi: 10.14309/ajg.0000000000000512.
    >> Share

  202. KLOMPENHOUWER AJ, Alblas M, van Rosmalen BV, Haring MPD, et al
    Response to Chen et al.
    Am J Gastroenterol. 2020;115:147-148.
    >> Share

  203. MOON AM, Yang JY, Barritt AS 4th, Bataller R, et al
    Rising Mortality From Alcohol-Associated Liver Disease in the United States in the 21st Century.
    Am J Gastroenterol. 2020;115:79-87.
    >> Share

  204. SINGAL AK, Arora S, Wong RJ, Satapathy SK, et al
    Increasing Burden of Acute-On-Chronic Liver Failure Among Alcohol-Associated Liver Disease in the Young Population in the United States.
    Am J Gastroenterol. 2020;115:88-95.
    >> Share

  205. DANG K, Hirode G, Singal AK, Sundaram V, et al
    Alcoholic Liver Disease Epidemiology in the United States: A Retrospective Analysis of 3 US Databases.
    Am J Gastroenterol. 2020;115:96-104.
    >> Share

    November 2019
  206. CAZZAGON N, Lemoinne S, El Mouhadi S, Trivedi PJ, et al
    The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2019 Nov 14. doi: 10.14309/ajg.0000000000000461.
    >> Share

  207. ALLEN AM, Therneau TM, Mara KC, Larson JJ, et al
    Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease: A Longitudinal Cohort Study.
    Am J Gastroenterol. 2019;114:1764-1771.
    >> Share

  208. HARRIS R, Card TR, Delahooke T, Aithal GP, et al
    Obesity Is the Most Common Risk Factor for Chronic Liver Disease: Results From a Risk Stratification Pathway Using Transient Elastography.
    Am J Gastroenterol. 2019;114:1744-1752.
    >> Share

    June 2019
  209. YOKODA RT, Carey EJ
    Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2019 Jun 4. doi: 10.14309/ajg.0000000000000268.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016